Cutaneous silent period in patients with restless leg syndrome

Clinical Neurophysiology

Volumn 118, Issue 8, 2007, Pages 1705-1710

  Han, Jin Kyu ^a,b   Oh, Kyungmi ^a   Kim, Byung Jo ^a   Koh, Seong Beom ^a   Kim, Ju Yeon ^a   Park, Kun Woo ^a   Lee, Dae Hie ^a  

^a Korea University Ansan Hospital   (South Korea)

^b Seoul Medical Center   (South Korea)

Author keywords

Cutaneous silent period; Dopamine agonist; Restless leg syndrome; Small fiber neuropathy

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; NERVOUS SYSTEM; NEURONS, AFFERENT; REACTION TIME; REFLEX; RESTLESS LEGS SYNDROME; SKIN; SPINAL CORD;

EID: 34447101505     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2007.04.024     Document Type: Article

References (22)

1. Clemens S., Rye D., and Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67 (2006) 125-130
2. Entezari-Taher M., Singleton J.R., Jones C.R., Meekins G., Petajan J.H., and Smith A.G. Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology 53 (1999) 1201-1205
3. Floeter M.K. Cutaneous silent periods. Muscle Nerve 28 (2003) 391-401
4. Fulda S., and Wetter T.C. Dopamine agonists for the treatment of restless legs syndrome. Expert Opin Pharmacother 6 (2005) 2655-2666
5. Garraway S.M., and Hochman S. Modulatory actions of serotonin, norepinephrine, dopamine, and acetylcholine in spinal cord deep dorsal horn neurons. J Neurophysiol 86 (2001) 2183-2194
6. Gemignani F., Brindani F., Negrotti A., Vitetta F., Alfieri S., and Marbini A. Restless legs syndrome and polyneuropathy. Mov Disord 21 (2006) 1254-1257
7. Gladwell S.J., and Coote J.H. Inhibitory and indirect excitatory effects of dopamine on sympathetic preganglionic neurones in the neonatal rat spinal cord in vitro. Brain Res 818 (1999) 397-407
8. Hogl B., and Poewe W. Restless legs syndrome. Curr Opin Neurol 18 (2005) 405-410
9. Inghilleri M., Cruccu G., Argenta M., Polidori L., and Manfredi M. Silent period in upper limb muscles after noxious cutaneous stimulation in man. Electroencephalogr Clin Neurophysiol 105 (1997) 109-115
10. Kutukcu Y., Dogruer E., Yetkin S., Ozgen F., Vural O., and Aydin H. Evaluation of periodic leg movements and associated transcranial magnetic stimulation parameters in restless legs syndrome. Muscle Nerve 33 (2006) 133-137
11. Leis A.A., Ross M.A., Emori T., Matsue Y., and Saito T. The silent period produced by electrical stimulation of mixed peripheral nerves. Muscle Nerve 14 (1991) 1202-1208
12. Nardone R., Ausserer H., Bratti A., et al. Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. Acta Neurol Scand 114 (2006) 244-249
13. Polydefkis M., Allen R.P., Hauer P., Earley C.J., Griffin J.W., and McArthur J.C. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 55 (2000) 1115-1121
14. Pullman S.L., Ford B., Elibol B., Uncini A., Su P.C., and Fahn S. Cutaneous electromyographic silent period findings in brachial dystonia. Neurology 46 (1996) 503-508
15. Scalise A., Pittaro-Cadore I., Golob E.J., and Gigli G.L. Absence of postexercise and delayed facilitation of motor cortex excitability in restless legs syndrome: evidence of altered cortical plasticity?. Sleep 29 (2006) 770-775
16. Serrao M., Parisi L., Valente G., et al. l-Dopa decreases cutaneous nociceptive inhibition of motor activity in Parkinson's disease. Acta Neurol Scand 105 (2002) 196-201
17. Shefner J.M., Berman S.A., and Young R.R. The effect of nicotine on recurrent inhibition in the spinal cord. Neurology 43 (1993) 2647-2651
18. Syed N.A., Sandbrink F., Luciano C.A., et al. Cutaneous silent periods in patients with Fabry disease. Muscle Nerve 23 (2000) 1179-1186
19. Trenkwalder C., Paulus W., and Walters A.S. The restless legs syndrome. Lancet Neurol 4 (2005) 465-475
20. Uncini A., Kujirai T., Gluck B., and Pullman S. Silent period induced by cutaneous stimulation. Electroencephalogr Clin Neurophysiol 81 (1991) 344-352
21. Walters A.S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10 (1995) 634-642
22. Walters A.S., LeBrocq C., Dhar A., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4 (2003) 121-132